News | Ultrasound Imaging | January 07, 2016

New Study Demonstrates Efficacy of Trophon EPR for Ultrasound Probe Disinfection

Results indicate traditional high-level disinfection methods do not completely inactivate human papillomavirus on probes

ultrasound probe disinfection, HPV, Trophon EPR, clinical study, Journal of Medical Virology

January 7, 2016 — A study published by the Journal of Medical Virology demonstrates that the trophon EPR is the only high-level ultrasound disinfection system proven to kill natural, infectious, high-risk, cancer-causing strains of human papillomavirus (HPV).

High-risk HPV accounts for 5 percent of all cancers worldwide, is responsible for almost all cases of cervical cancer and is a leading cause of oral, throat, anal and genital cancers.

A number of published studies have already demonstrated there is a real risk of cross contamination between patients examined with ultrasound probes. The studies showed up to 7 percent of vaginal ultrasound probes remained contaminated with HPV despite the use of probe covers and routine disinfection. HPV is also a very stable virus and is able to remain infectious on fomites and surfaces for days despite routine disinfection.

Testing of natural, infectious “real” HPV has not previously been possible due to the difficulties of growing enough of the natural, infectious virus for research.

This situation changed recently when researchers from Penn State College of Medicine and Brigham Young University in the United States developed a method to grow HPV. “We were the first ever to grow papillomavirus in culture,” said Craig Meyers, distinguished professor of microbiology and immunology, Penn State College of Medicine. “In our original study we chose, specifically, glutaraldehyde and ortho-phthalaldehyde (OPA) to test because these are disinfectants that hospitals believe are sterilants that kill everything, including papillomavirus.”

This original study, which was published in 2014, showed both glutaraldehyde and OPA completely failed to inactivate natural, infectious, high-risk HPV16 – even after 24 hours of contact time. The most recent study used a stringent method in line with U.S. Food and Drug Administration (FDA) requirements for virucidal testing. OPA was retested and the trophon EPR device tested against HPV16 and HPV18, which are the major cancer-causing types of HPV. The results showed that the trophon EPR was the only disinfectant to completely inactivate HPV.

“Our first study showed that commonly used disinfectants are not effective, while this latest study found that trophon EPR was completely effective. The concern is that these other liquid chemical disinfectants are commonly used in medical and healthcare facilities. Where this is happening, HPV is not being killed, posing a risk for transmission,” said Meyers.

The study concluded that healthcare professionals should carefully consider these results when selecting appropriate disinfection methods and that a review of disinfection standards with respect to high-level disinfection may be warranted.

“Publication of the study is very timely given the current increased scrutiny of disinfection practices, said Michael Kavanagh, Nanosonice CEO and president. “An alert issued in the U.S. by the Centers for Disease Control and the FDA in September stipulates that reusable medical devices, such as ultrasound probes, must be properly maintained, cleaned and disinfected/sterilized and urged healthcare facilities to immediately review current reprocessing practices to protect patients.”

According to Kavanagh, the trophon technology uses a proprietary disinfectant containing a high concentration of hydrogen peroxide that is sonically activated to form a sub-micron particle mist. The mist generates a high number of free radicals with superoxidative properties that destroy the virus. Traditionally, ultrasound probes are soaked in toxic liquid chemicals or manually wiped for a few minutes with a pre-impregnated wipe.

For more information: www.nanosonics.com.au

Related Content

Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Ultrasound Imaging | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cardiac Imaging | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Siemens Healthineers Announces First Installation of Acuson Sequoia Ultrasound
News | Ultrasound Imaging | September 20, 2018
September 20, 2018 — Siemens Healthineers announced the first global installation of its newest...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools,...
Exact Imaging Partners to Improve Prostate Cancer Detection With Artificial Intelligence
News | Prostate Cancer | September 19, 2018
Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to...
Acuson Sequoia
News | Ultrasound Imaging | September 12, 2018
Siemens Healthineers announced the first global installation of its newest ultrasound system, the...
Mount Sinai Serves as Official Medical Services Provider for 2018 U.S. Open
News | Orthopedic Imaging | September 06, 2018
For the sixth consecutive year, Mount Sinai will serve as the official medical services provider for the 2018 U.S. Open...
Konica Minolta Provides Sonimage HS1 Ultrasound for AAPM&R Hands-on Learning Course
News | Ultrasound Imaging | September 05, 2018
Konica Minolta Healthcare Americas recently provided ultrasound systems for The American Academy for Physical Medicine...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...